M. Robinson

发表

Alterations of TP53 in microdissected transitional cell carcinoma of the human urinary bladder: high frequency of TP53 accumulation in the absence of detected mutations is associated with poor prognosis.

D. Neal, R. Abdel-Fattah, C. Challen, 1998, British Journal of Cancer.

Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer.

T B Lam, C Fraser, D. Neal, 2012, Health technology assessment.

Neural network analysis of combined conventional and experimental prognostic markers in prostate cancer: a pilot study.

D. E. Neal, F. Hamdy, D. Neal, 1998, British Journal of Cancer.

p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate.

D. Neal, D. Lane, M. Robinson, 1992, The Journal of urology.

c-jun oncogene expression in transitional cell carcinoma of the urinary bladder.

D. Neal, M. Robinson, C. Horne, 1994, British journal of urology.

Abnormalities in p53 and DNA content in transitional cell carcinoma of the bladder.

D. Neal, M. Robinson, K. Mellon, 1994, British journal of urology.

TP53 accumulation predicts improved survival in patients resistant to systemic cisplatin-based chemotherapy for muscle-invasive bladder cancer.

D. Neal, M. Robinson, J. Lunec, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

TP 53 Accumulation Predicts Improved Survival in Patients Resistant to Systemic Cisplatin-based Chemotherapy for Muscle-invasive Bladder Cancer 1

D. Neal, M. Robinson, J. Lunec, 1999 .

Cell cycling in bladder carcinoma determined by monoclonal antibody Ki67.

D. Neal, M. Robinson, K. Mellon, 1990, British journal of urology.

The immunohistochemical detection of cripto‐1 in benign and malignant human bladder

D. Neal, M. Robinson, W. Gullick, 1998, The Journal of pathology.

Bladder carcinosarcomas: three cases with diverse histogenesis

M. Robinson, M. Bennett, C. Bloxham, 1990, Histopathology.

P53 expression, ploidy and progression in pT1 transitional cell carcinoma of the bladder.

D. Neal, M. Robinson, B. Shenton, 1994, British journal of urology.

p53 expression and clinical outcome in prostate cancer.

T. Hasan, D. Neal, M. Robinson, 1993, British journal of urology.

bcl-2 overexpression combined with p53 protein accumulation correlates with hormone-refractory prostate cancer.

F. Hamdy, D. Neal, J. Royds, 1996, British Journal of Cancer.

P53 and Ki-67 immunoreactivity in human prostate cancer and benign hyperplasia.

D. Neal, M. Robinson, K. Mellon, 1992, British journal of urology.

Primary choriocarcinoma of the urinary bladder: a case report.

M. Robinson, J. Roberts, P. Ramsden, 1996, Clinical oncology (Royal College of Radiologists (Great Britain)).

Renal carcinoma with adjacent retroperitoneal fibrosis.

D. Neal, M. Robinson, J. Forsythe, 1989, British Journal of Urology.

Caveolin-1 expression is associated with high-grade bladder cancer.

M. Robinson, J. Mellon, G. Durkan, 2001, Urology.

The expression of waf-1, p53 and bcl-2 in prostatic adenocarcinoma.

F. Hamdy, D. Neal, M. Robinson, 1997, British journal of urology.

Immunolocalization and messenger RNA expression of bone morphogenetic protein-6 in human benign and malignant prostatic tissue.

F. Hamdy, D. Neal, C. Robson, 1997, Cancer research.

Glutathione-S-Transferase π Expression in Transitional Cell Carcinoma of the Bladder

D. Neal, M. Robinson, S. Clifford, 1993 .

Cripto-1 is a tumour specific marker of bladder cancer

D. Neal, M. Robinson, W. Gullick, 1997 .

Late Onset Classical Seminoma in a Sib Pair with Possible Familial Aetiology

M. Robinson, I. Pedley, B. Gowardhan, 2002, Scandinavian journal of urology and nephrology.